A Trial of the Safety and Efficacy of Single-Dose Administration of ANB-010 in Subjects With Hemophilia A

NCT06185335 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

GENETIC: ANB-010, dose 1
GENETIC: ANB-010, dose 2
GENETIC: ANB-010, dose 3

Sponsor

Biocad